117 related articles for article (PubMed ID: 22827574)
21. Selective expression of claudin-5 in thymic endothelial cells regulates the blood-thymus barrier and T-cell export.
Nagatake T; Zhao YC; Ito T; Itoh M; Kometani K; Furuse M; Saika A; Node E; Kunisawa J; Minato N; Hamazaki Y
Int Immunol; 2021 Mar; 33(3):171-182. PubMed ID: 33038259
[TBL] [Abstract][Full Text] [Related]
22. Functional Analysis of Membrane-Associated Scaffolding Tight Junction (TJ) Proteins in Tumorigenic Characteristics of B16-F10 Mouse Melanoma Cells.
Ko EJ; Kim DY; Kim MH; An H; Kim J; Jeong JY; Song KS; Cha HJ
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255907
[TBL] [Abstract][Full Text] [Related]
23. Blood-Brain Barrier Protein Claudin-5 Expressed in Paired
Brunner N; Stein L; Cornelius V; Knittel R; Fallier-Becker P; Amasheh S
Front Physiol; 2020; 11():857. PubMed ID: 32848831
[TBL] [Abstract][Full Text] [Related]
24. Fusobacterium nucleatum putatively affects the alveoli by disrupting the alveolar epithelial cell tight junction, enlarging the alveolar space, and increasing paracellular permeability.
Karahashi Y; Cueno ME; Kamio N; Takahashi Y; Takeshita I; Soda K; Maruoka S; Gon Y; Sato S; Imai K
Biochem Biophys Res Commun; 2023 Nov; 682():216-222. PubMed ID: 37826945
[TBL] [Abstract][Full Text] [Related]
25. Zonula Occludens Proteins Signaling in Inflammation and Tumorigenesis.
Yu S; He J; Xie K
Int J Biol Sci; 2023; 19(12):3804-3815. PubMed ID: 37564207
[TBL] [Abstract][Full Text] [Related]
26. X-Ray Conformation and Structure-Activity Relationships of MA026, a Reversible Tight Junction Opener.
Mukaiyama M; Uchiyama C; Fukuda A; Nakazawa Y; Kuramochi Y; Shibata Y; Konno S; Muguruma K; Matsugaki N; Asari T; Ogawa K; Taguchi A; Takayama K; Taniguchi A; Nagumo Y; Senda T; Hayashi Y; Usui T
J Med Chem; 2023 Jul; 66(13):8717-8724. PubMed ID: 37352439
[TBL] [Abstract][Full Text] [Related]
27. Cytoskeleton remodelling of confluent epithelial cells cultured on porous substrates.
Rother J; Büchsenschütz-Göbeler M; Nöding H; Steltenkamp S; Samwer K; Janshoff A
J R Soc Interface; 2015 Feb; 12(103):. PubMed ID: 25566882
[TBL] [Abstract][Full Text] [Related]
28. High-Frequency Irreversible Electroporation (H-FIRE) Induced Blood-Brain Barrier Disruption Is Mediated by Cytoskeletal Remodeling and Changes in Tight Junction Protein Regulation.
Partridge BR; Kani Y; Lorenzo MF; Campelo SN; Allen IC; Hinckley J; Hsu FC; Verbridge SS; Robertson JL; Davalos RV; Rossmeisl JH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740406
[TBL] [Abstract][Full Text] [Related]
29. Crumbs2 mediates ventricular layer remodelling to form the spinal cord central canal.
Tait CM; Chinnaiya K; Manning E; Murtaza M; Ashton JP; Furley N; Hill CJ; Alves CH; Wijnholds J; Erdmann KS; Furley A; Rashbass P; Das RM; Storey KG; Placzek M
PLoS Biol; 2020 Mar; 18(3):e3000470. PubMed ID: 32150534
[TBL] [Abstract][Full Text] [Related]
30. Development of the evaluation system for barrier functions of engineered epithelial lumens.
Furusawa K; Mizutani T; Sasaki N
Regen Ther; 2016 Mar; 3():82-89. PubMed ID: 31245477
[TBL] [Abstract][Full Text] [Related]
31. Horizontal and vertical microchamber platforms for evaluation of the paracellular permeability of an epithelial cell monolayer.
Kida R; Tsugane M; Suzuki H
Lab Chip; 2024 Jan; 24(3):572-583. PubMed ID: 38175144
[TBL] [Abstract][Full Text] [Related]
32. Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells.
Krug SM; Amasheh M; Dittmann I; Christoffel I; Fromm M; Amasheh S
Biomaterials; 2013 Jan; 34(1):275-82. PubMed ID: 23069717
[TBL] [Abstract][Full Text] [Related]
33. Saturated Fatty Acid Emulsions Open the Blood-Brain Barrier and Promote Drug Delivery in Rat Brains.
Sung KS; Cho WH; Cha SH; Kim YW; Choi SH; Kim HJ; Yun MS
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399300
[TBL] [Abstract][Full Text] [Related]
34. Challenges and prospects in geriatric epilepsy treatment: the role of the blood-brain barrier in pharmacotherapy and drug delivery.
Chen X; Luo J; Song M; Pan L; Qu Z; Huang B; Yu S; Shu H
Front Aging Neurosci; 2024; 16():1342366. PubMed ID: 38389560
[TBL] [Abstract][Full Text] [Related]
35. Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders.
Patharapankal EJ; Ajiboye AL; Mattern C; Trivedi V
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258077
[TBL] [Abstract][Full Text] [Related]
36. Expression of Cell-Adhesion Molecules in
Rollins J; Worthington T; Dransfield A; Whitney J; Stanford J; Hooke E; Hobson J; Wengler J; Hope S; Mizrachi D
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372932
[TBL] [Abstract][Full Text] [Related]
37. Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery.
Ramirez-Velez I; Belardi B
Adv Drug Deliv Rev; 2023 Aug; 199():114905. PubMed ID: 37271282
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
Kim JC; Park EJ; Na DH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
[TBL] [Abstract][Full Text] [Related]
39. Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins.
Qin L; Cui Z; Wu Y; Wang H; Zhang X; Guan J; Mao S
Pharm Res; 2023 May; 40(5):1037-1055. PubMed ID: 36385216
[TBL] [Abstract][Full Text] [Related]
40. The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil.
Markovic M; Zur M; Garsiani S; Porat D; Cvijić S; Amidon GL; Dahan A
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
